Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
REGENERX BIOPHARMACEUTICALS INC (RGRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/06/2023 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 36.1% stake in RegeneRx Biopharmaceuticals, Inc. |
| 10/16/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/16/2019 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 33.9% stake in RegeneRx Biopharmaceuticals, Inc. |
| 03/01/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/27/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/28/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/14/2018 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 30.6% stake in RegeneRx Biopharmaceuticals, Inc. |
| 10/17/2017 |
SC 13D/A
| Sinaf S.A. reports a 25.2% stake in RegeneRx Biopharmaceuticals, Inc. |
| 04/01/2015 |
SC 13D/A
| G-treeBNT Co., Ltd. reports a 19.3% stake in RegeneRx Biopharmaceuticals, Inc. |
| 09/03/2014 |
SC 13D/A
| G-treeBNT Co., Ltd. reports a 23.5% stake in RegeneRx Biopharmaceuticals, Inc. |
| 04/01/2014 |
SC 13D/A
| G-treeBNT Co., Ltd. reports a 23.5% stake in RegeneRx Biopharmaceuticals, Inc. |
| 12/23/2013 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 33.5% stake in RegeneRx Biopharmaceuticals, Inc. |
| 09/24/2013 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 33.5% stake in RegeneRx Biopharmaceuticals, Inc. |
| 09/24/2013 |
SC 13D/A
| DEFIANTE FARMACEUTICA LDA reports a 33.5% stake in RegeneRx Biopharmaceuticals, Inc. |
| 09/24/2013 |
SC 13D/A
| CAVAZZA PAOLO reports a 33.5% stake in RegeneRx Biopharmaceuticals, Inc. |
| 09/24/2013 |
SC 13D/A
| Sinaf S.A. reports a 33.5% stake in RegeneRx Biopharmaceuticals, Inc. |
| 09/24/2013 |
SC 13D/A
| Taufin International S.A. reports a 33.5% stake in RegeneRx Biopharmaceuticals, Inc. |
| 10/25/2012 |
SC 13D/A
| Taufin International S.A. reports a 31.6% stake in RegeneRx Biopharmaceuticals, Inc. |
| 10/25/2012 |
SC 13D/A
| Sinaf S.A. reports a 31.6% stake in RegeneRx Biopharmaceuticals, Inc. |
| 10/25/2012 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/25/2012 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/25/2012 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/14/2011 |
SC 13D/A
| Taufin International S.A. reports a 32.7% stake in RegeneRx Biopharmaceuticals, Inc. |
| 01/14/2011 |
SC 13D/A
| Sinaf S.A. reports a 32.7% stake in RegeneRx Biopharmaceuticals, Inc. |
| 01/14/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/14/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/14/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/14/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/14/2010 |
SC 13D/A
| Taufin International S.A. reports a 31.7% stake in RegeneRx Biopharmaceuticals, Inc. |
| 07/09/2010 |
SC 13D/A
| Sinaf S.A. reports a 31.7% stake in RegeneRx Biopharmaceuticals, Inc. |
| 07/09/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/09/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/09/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/09/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|
|